chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient developed slurred speech one day after. She went to ER after 2 days. She had a negative Ct of her head and negative for carotid thrombosis. She was well anticoagulated at INR 3.0 on 9/27/21 the date of her vaccine.
He got the vaccine, he came home and was very weak, maybe a little bit of a low grade temp.  Went to bed, got up the next morning and felt okay other than weakness and had to get a caregiver to help take care of his wife as he was not able to.  Had a temp last night of 101.9, weakness to the point that he is falling over, no equilibrium at all, not able to get himself up from the couch last night.  Very active gentleman for his age, so this is very unusual for him and it scared him that he was not able to get up.  He has a severe headache since having the vaccine.  He does have a large knot where he got the vaccine, as well as redness and soreness.  He is still feeling the same today, very very weak, no temp though.  4/22/21.  He did take 2 Advil for his temp yesterday and hasn't had anything today.
Left arm at injection site is still red, in a circle around site, hot to the touch and itchy. Moderna COVID-19 vaccine ELLA
Patient waiting in line at fast food restaurant.  Became stiff, fell to floor, tonic clonic movements lasting 30-40 sec.  Brought to ER for further eval, no further problem following seizure.
Adverse reactions included regression. She quit smiling and laughing. She no longer slept through the night like she had been. Inconsolable crying for 2 days following the shot. 105 fever that lasted two weeks. Rash and knots in both her legs. Immediately following she fell ill with what seems to be a common cold but still has been unable to fight it off. She also still struggles with sleep.
Her friend has had both Covid 19 vaccines and has developed pericarditis; This is a spontaneous report from a contactable consumer (patient's friend) via the Pfizer-sponsored Program. A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date (batch/lot number was not reported) as DOSE 1, SINGLE and received the second dose of BNT162B2 (PFIZER BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date (batch/lot number was not reported) as DOSE 2, SINGLE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The consumer reported that her friend has had both COVID-19 vaccines and has developed pericarditis on an unspecified date. Her friend will have some tests next week. The outcome of the event pericarditis was unknown.   The batch/lot numbers for BNT162B2 were not provided and will be requested during follow-up.
pt recvd pneumococcal vax 315PM on 26NOV91 & later that evening exp achiness, nausea, vomiting, h/a, weakness, as well as induration, heat, pain, redness, & swelling @ inject site which measured 7x7 cm; also fever of 102, backache, arthralg
No adverse event; Improperly stored vaccine; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. Information regarding the patient's medical history, concurrent conditions or concomitant medications was not provided.  On 16-NOV-2020, the patient was vaccinated with an improperly stored dose of hepatitis b vaccine (recombinant)(RECOMBIVAX HB) (lot # S005809, which was verified to be a valid lot number, expiration date reported and upon internal validation established as 02-NOV-2021) for prophylaxis (dose, route of administration, vaccination scheme frequency, and anatomical location were not reported). The administered dose of the vaccine experienced a temperature excursion 3 degrees Fahrenheit (F) for 3 hours and 30 minutes, as recorded by a data logger. There was no adverse effect reported.
When I was documenting the vaccines given I then realize that I had given Vaxelis and had also given a dose on HIB that did not need to be given.
Fever (100 - 102.8 F), runny nose, restless sleep, followed by red, raised rash on 10/03/2016.
After receiving shot, pt went to cafeteria to get lunch. After eating started having pains under left breast, she originally thought was gas pain. Pain was slightly stabbing in nature. Heart was pounding, took her BP and pulse. BP was 140/80 pulse was 153 beats/min, went to ER diagnosed with A-fibrillation and was admitted.
Patient discharged after (8) day inpatient stay. 11/12-11/20/21  PT is a 41 y.o. female who is 1y2m s/p allo HSCT for ALL, who was admitted for COVID-19. Diagnosed 11/4/21 despite being full vaccinated as of April 2021. Completed a 9 day course of decadron however will be discharged on pred 40 mg PO daily given recent liver biopsy positive for GVHD. Patient to also continue budesonide 3 mg TID and to resume tacro 0.5 BID. Regarding COVID, patient received remdesivir and MAB. To be discharged on supplemental O2 as coordinated by pulm rehab. To have telehealth appt with LHCP 11/23 @ 10am (will not need labs).
09:32 Patient reported lightheadedness and dizziness to physician upon standing in room after immunization while getting ready to leave. Dr. advised patient to sit and requested to move patient to room with a chair that leaned back. Patient and father reported patient felt well enough to walk to other exam room. 09:34am Patient requested to stop and use the bathroom, nurse requested father go with patient. Patient turned on light and reported he couldn't see the light, father supported patient, patient's legs went weak. Nursing staff gathered chair for patient to sit. Patient became very pale, diaphoretic, and noted decreased level of consciousness. @09:36 Unable to obtain BP, P - 50, R - 16, O2 sat 99%. Dr. called ER, reported to Dr. who accepted patient. Nursing staff applied cool compress to patient's neck. Patient cooperative, verbally communicating, still appears diaphoretic and pale. Father remains at patient's side. Patient escorted to ER and care turned over. Patient was given oral electrolytes in ER, monitiored, and discharged to home 07/03/23@10:55am.
pfizer vacc covid-19 5-11y 1st dose @ 12:30pm, no reaction immediately post vaccination. However, during post-vaccination observation period & @ around 1pm the patient's mother called out that the patient complains of itching all over the body, ears are red, and face is flushed. I asked the patient's mother and the patient to come back into the immunization room. After noting the redness in the patient's ears, I asked and the mother agreed to give the patient a dose of diphenhydramine to control the allergic reaction. Per the mother, the patient is 65lbs therefore per emergency protocol the patient was given 12ml of diphenhydramine12.5mg/5ml x1dose (30mg) with water. We observed patient for 30min. and since the mother expressly acknowledges that all symptoms of the adverse reaction have passed, the patient was released w/the mother. We gave instruction for the mother to contact md if patient's/ re-appeared. Per the patient's mother, the patient's PCP is (Privacy), I was unable to reach since the office is closed on the weekend. I will contact the patient's mother in 24hrs to follow-up.
Patient had gradual onset of urinary retention and a mix of upper/lower motor neuron dysfunction.  Currently going under workup for acute demyelinating polyneuropathy. Currently admitted to Medical Center, receiving Solumedrol, undergoing plasma exchange.
Pt became gray in the face within 20 minutes after receiving FLUZONE HD and ZOSTAVAX. He reported tingling lips and chest tightness. I inquired about calling his PCP, to which he agreed. I contacted Dr, to whom patient spoke briefly. Dr advised me to activate EMS Protocol, administer EPIPEN 0.3 mg IM, and call 911. Pt reported easier breathing after administration of EPIPEN. EMS arrived within 5 minutes and pt was transported to local ER.
received vaccine on 01/20/21.   02/06/21vomiting, difficulty eating, hypotension, sent to hospital and admitted with hypotension and hypothermia, placed on Bi-pap,  02/15/21 resident returned to facility under hospice care, expired on 02/24/2021
1122-Patient received vaccine 1135-Patient reported feeling numbness in hands 1138-Patient given snack and water 1150-Patient reported feeling much better; EE observed at vaccine clinic 1230-Patient departed vaccine clinic reporting a resolution of symptoms
Patient experienced fever, chills, fatigue, decreased appetite, headache, lightheadedness, and swollen and tender lymph nodes in the right supraclavicular area and the right axillary area. When he presented to the clinic on 12/04/2021, most of the symptoms had resolved except the swollen and tender lymph nodes in the right supraclavicular and axillary areas, fatigue, and minor lightheadedness.   Recommend Tylenol, as needed, for pain and fever greater than 100.4 F and cool compress to the supraclavicular and axillary areas. He was instructed to follow up with primary care this coming Monday, and go to the emergency room if symptoms become worse.
7-31-18 -Started with a blotchy rash from head to toe, gave BENADRYL, by 8-1-18 at 7:57am rash was better, still a little blotchy. Rash completely resolved by 8/4/18. Rash: Erythema on arms and legs; splotchy on face, neck, trunk.
Sz of 30 seconds approx 230PM; 2nd sz approx 355PM; 3rd sz approx 520PM; transmitted to Hosp arrived approx 715; sz in ambulance & ER; tx Clonopin then Phenobarbital;
On Mon, April 5, had the vaccine, fainted at site 5 minutes after getting the vaccine. 9pm Apr 5, had fatigue, fever, slight headache, night sweats, clammy skin feeling. This continued until Wed Apr 7th Wed Apr 7 and Thursday Apr 8th were fine Friday, Apr 9th developed all of the above issues plus dizziness, nausea, upset stomach and dry heaving. This continued into Sat Apr 10th with added shortness of breath and heart palpatations. Went to the emergency room Sat Apr 10th Sunday, Apr 11th, severe nausea and stomach problems continuing along with continued night sweats.
3 inches around the injection site is red, warm and hard; 3 inches around the injection site is red, warm and hard; 3 inches around the injection site is red, warm and hard; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (3 inches around the injection site is red, warm and hard), VACCINATION SITE WARMTH (3 inches around the injection site is red, warm and hard) and VACCINATION SITE INDURATION (3 inches around the injection site is red, warm and hard) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.     Concurrent medical conditions included Cholesterol. Concomitant products included ROSUVASTATIN for Cholesterol.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Apr-2021, the patient experienced VACCINATION SITE ERYTHEMA (3 inches around the injection site is red, warm and hard), VACCINATION SITE WARMTH (3 inches around the injection site is red, warm and hard) and VACCINATION SITE INDURATION (3 inches around the injection site is red, warm and hard). At the time of the report, VACCINATION SITE ERYTHEMA (3 inches around the injection site is red, warm and hard), VACCINATION SITE WARMTH (3 inches around the injection site is red, warm and hard) and VACCINATION SITE INDURATION (3 inches around the injection site is red, warm and hard) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       treatment products included Advil
Dizziness, Diarrhea, HYPERtension & Tachycardia Narrative: Mild dizziness 5 minutes after vaccination. 167/110, heart rate 77 at 1408. 144/01, heart rate 68 at 1417. Reported mild anxiety. Observed 30 minutes. No e/o allergic reaction and anxiety resolved.
pt recvd vax;at noc,exp severe abdo cramps;sxs has not resolved;
Started menstrual cycle about 1 week early.  Irregularity is highly unusual and of concern.  Otherwise no ill effect other than swelling at injection site.
I developed a sinus infection on May 1, 2021. I developed pneumonia in June 2021. On September 1, 2021 I was diagnosed with Croupous bronchitis.
On Saturday, one day after receiving booster dose (0.25 ml) of Moderna, the patient experienced swelling, redness, and pain in the armpit area of her left arm. When she presented to the pharmacy on Monday, it was no longer red and the pain and swelling had decreased (though still visible).
Within 2 min. after vaccination, pt. became unresponsive, had stare & eyes glassy in appearance, grunting w/body rigidity & LOC about 15 seconds w/ urinary incontinence. Ftr. states this had occurred after childhd. vaccinations & more recently w/ blood draw - undisclosed at the time of vaccination. Pt. also dieting (? type per ftr.) & had not eaten prior to vaccination. Cool compress, H2O given. Pt had no memory of incident - driven home per ftr.
Starting about 2 1/2 days after the first dose I had aches, significant fatigue, nausea, some subjective fever and slight chills. All of this last 12 days. About 1 week into symptoms also noted some mild shortness of breath and cough. All eventually resolved after 12 days with the nausea being the last symptom to resolve. With the second dose, I felt fine aside from a large red, tender knot on my arm. About 4 weeks later started developing several sizeable pink, indurated areas which did not hurt or itch. the first 3 happened to be in surgical scars- one on right calf, one on left anterior thigh and largest one on right wrist which was 3-4 inches long and felt maybe 1/2-1 inch deep. Then developed similar on right lower eyelid. I did not have a previous scar here. Last to develop was on left upper eyelid and felt shaped more like a BB. At this point, I asked opinion of one of my partners (we are family medicine physicians) and he agreed that it seemed like a reaction to something.  I started taking some ibuprofen for anti-inflammatory symptoms and then took prednisone 20 mg daily for 5 days which did seem to help them resolve, however I still have small palpable areas on right leg and wrist. I have never had an adverse reaction to another medication or vaccine. My vaccines are all current and the last time I was sick enough to miss work was 2004, so I didn't have any other obvious explanation for this.
Started with scratchy throat mid-day.  Not sure if related.  In mid-afternoon, after eating apple with peanut butter, noted swollen lips (inside of mouth tissue around the lips as much as the lips themselves) and gland at center of mouth below tongue, then felt flu-like systems until present (11 am next day).  Took benadryl immediately upon swelling.  Starting to feel a bit better around now.  Symptoms have been the aches and chills and congestion similar to flu.
pt recv vax 3OCT97 p/1PM on Saturday had redness on arm-5OCT97 itching, redness & 3-4blisters @ inj site;coughing & rhinitis, sneezing;6OCT97 blisters happened red area oblong in sharp-blisters drying up;feels better now;
Lack of Efficacy - positive COVID swab + COVID symptoms; Lack of Efficacy - positive COVID swab + COVID symptoms; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 21Jan2021 as dose 1, single (Lot number: EL3247), in left arm, on 11Feb2021 as dose 2, single (Lot number: EL3247), in left arm and on 04Nov2021 as dose 3 (booster) , single (Lot number: FF8841) at the age of 39 years, in left arm, all intramuscular for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported.  The following information was reported: VACCINATION FAILURE (medically significant) with onset 02May2022, outcome "not recovered", COVID-19 (medically significant) with onset 02May2022, outcome "not recovered" and all described as "Lack of Efficacy - positive COVID swab + COVID symptoms". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (02May2022) Positive, notes: Nasal Swab. Therapeutic measures were not taken as a result of vaccination failure, covid-19.  Clinical course: Patient did not received other vaccine within 4 weeks of Coivd-19 vaccine. Patient did not had covid 19 prior to the vaccination and patient tested for covid post vaccination and no known allergy.
Large red hard swollen spot at injection site. Itchy, hot to touch, painful, swollen and hard feeling
This is an instance of breakthrough COVID-19 after which death occurred. The individual was vaccinated with the Pfizer product on 01/11/2021 and 02/01/2021. They had both a positive and a negative antigen test on 10/29/2021 and a positive PCR test on 10/29/2021. All three of these tests were administered at the facility at which the individual was a resident. They .had a hospital encounter 10/27/2021 and were discharged 11/04/2021. The chief complaints/problems for this hospital encounter included: unspecified pain, COVID-19, palliative care, Type I Diabetes, unspecified anxiety disorder, and dementia. The individual died on 11/06/2021.
Feels ill; Abnormal fatigue; Chills; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Feels ill), FATIGUE (Abnormal fatigue) and CHILLS (Chills) in a 90-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MALAISE (Feels ill), FATIGUE (Abnormal fatigue) and CHILLS (Chills). At the time of the report, MALAISE (Feels ill), FATIGUE (Abnormal fatigue) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication information was provided. No treatment medication information was provided.    Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2021: Follow-up received and contains No new Information.
Initial information has been received from a health professional and follow-up information was received from a physician, for the Pregnancy Registry for GARDASIL, concerning a 20 year old white female with depression, sciatica, drug hypersensitivity to PHENERGAN and amoxicillin and a history of 1 previous pregnancy (1 full-term delivery), cervical dysplasia, right ovarian cystectomy (2006), and loop electrosurgical excision of transformation zone procedure (LEETZ, in 2007). On 07-FEB-2008 the patient was vaccinated with the first dose GARDASIL (lot# not provided). On 13-FEB-2008 the patient had a positive blood test for pregnancy (LMP 15-JAN-2008) and an ultrasound on 27-FEB-2008 (IUP 8w5d). On approximately March 2008, the patient developed GARDNERELLA vaginitis. On 25-MAR-2008  the patient was placed on therapy with PROZAC, 20 mg, once a day, orally, for the treatment of depression and FLAGYL, 500 mg, twice a day, orally, for the treatment of GARDNERELLA vaginitis. On 30-JUN-2008 therapy with PROZAC was discontinued. On 01-JUL-2008 therapy with FLAGYL was discontinued. The outcome of GARDNERELLA vaginitis was unknown. On approximately 28-JUL-2008, the patient developed preterm labor at 30 weeks gestation. On 28-JUL-2008 the patient was placed on CELESTONE, 12 mg, every 12 hours, intramuscularly and magnesium sulfate, 2 gram every hour for the treatment of preterm labor. On 29-JUL-2008 therapy with CELESTONE was discontinued. On 30-JUL-2008 therapy with magnesium sulfate was discontinued and the patient was placed on terbutaline sulfate, 2.5 mg, every 4 hours, orally, for the treatment of preterm labor. On 11-AUG-2008 therapy with terbutaline sulfate was discontinued and the patient was placed on an unspecified medication, 10 mg, every 6 hours, orally, for the treatment of preterm labor. On the same day, the unspecified medication was discontinued. On 09-SEP-2008 the patient delivered a 7 pounds 6 ounces normal boy. The baby was diagnosed with sleep apnea and gastric reflux. Additional information is not expected.
POTENTIAL ADMINISTRATION OF EXPIRED VACCINE; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: 19-SEP-2021) dose was not reported, administered on 15-OCT-2021 for prophylactic vaccination (Dose series number : 1). No concomitant medications were reported. On 15-OCT-2021, the patient experienced potential administration of expired vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of potential administration of expired vaccine was not reported. This report was non-serious.
Buzzing in the ear continued for a day Then returned with more ringing after the second vaccine dose and continued intermittently for about four months, with pronounced dizziness occasionally. Daily ringing, buzzing, and now hearing loss after 3rd (booster) - all Pfizer vaccines
14UAG97 11MA pt came in & recv immunization;pt had a full body sz directly p/vax;lasted 30sec was then seen by MD & pt had lab ordered;pt exam was negative per MD;
Swollen on one of the legs; swollen and hurt knee; swollen and hurt knee; This is a spontaneous report received from a contactable consumer (friend). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration, on an unspecified date as a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced swollen on one of the legs and swollen and hurt knee on an unspecified date. It was reported that the reporter's friend told her that she went to her doctor (at the hospital) about her knee and she said it was swollen and hurt on the side of her leg she was swollen. She did not know if she bumped into anything, but all of a sudden, the swelling came up on her leg. The clinical outcome of swollen on one of the legs and swollen and hurt knee was unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
VOMITING; NECK PAIN; MALAISE; ARM SORENESS/PAIN WAS ACROSS SHOULDER; This spontaneous report received from a patient concerned a 75 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978, and expiry: UNKNOWN) dose was not reported, administered on 03-APR-2021 in right arm for prophylactic vaccination. No concomitant medications were reported. On 03-APR-2021, the subject experienced vomiting. On 03-APR-2021, the subject experienced neck pain. On 03-APR-2021, the subject experienced malaise. On 03-APR-2021, the subject experienced arm soreness/pain was across shoulder. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from vomiting on 04-APR-2021, and malaise on 06-APR-2021, was recovering from arm soreness/pain was across shoulder, and had not recovered from neck pain. This report was non-serious.
Backbone pain, tolerable but constant. On the low side, after 4 hours of getting vaccinated. Before, some minutes of numbness in the left side of the head, like 1 hour
Ten days after receiving the injection I noticed a 2? by 2? red, slightly raised, slightly warm lump at the injection site that itches.
5 MINUTES AFTER GETTING THE VACCINATION, PATIENT FAINTED WHILE SITTING IN THE CHAIR AND WAS GASPING FOR AIR FOR A FEW SECONDS BUT CAME TO RIGHT AWAYS AND SEEMED ALERT. PATIENT REPORTED EXTREME NAUSEA AND WAS SWEATING PROFUSELY. EMS was contacted and patient was taken to the hospital. A lot of tests were ran and it was concluded that patient vasovagled and was released from the hospital.